Drugs / Chlorhexidine-alcohol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00290290 | Sep 2003 → May 2008 | — | Baylor College of Medicine | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03640507 Comparator | Oct 2018 → May 2019 | — | Columbia University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chlorhexidine-alcohol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00290290 ↗ |
| Known as | Chloraprep | “This trial is to compare the impact of disinfecting the skin with Chloraprep (2%chlorhexidine and 70% isopropyl alcohol) vs. Betadine” NCT00290290 ↗ |
| Route | Topical | “Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.” NCT03640507 ↗ |